Clay minerals-based drug delivery systems for anti-tuberculosis drugs

S Saadat, D Rawtani, G Parikh - Journal of Drug Delivery Science and …, 2022 - Elsevier
Clay minerals-based nanocarriers for anti-tuberculosis drugs have attracted a lot of
consideration in recent decades owing to their exceptional characteristics including high …

Know your tuberculosis epidemic–Is it time to add Mycobacterium tuberculosis immunoreactivity back into global surveillance?

HM Rickman, W Kamchedzera, A Schwalb… - PLOS Global Public …, 2022 - journals.plos.org
Tuberculosis (TB) still causes 1.5 million deaths globally each year. Over recent decades,
slow and uneven declines in TB incidence have resulted in a falling prevalence of TB …

Tuberculosis prevalence: beyond the tip of the iceberg

RMGJ Houben, H Esmail, F Cobelens… - The Lancet …, 2022 - thelancet.com
The global burden of tuberculosis disease remains stubbornly high. Population surveys
estimate that 14 million individuals have prevalent disease, reflecting around 10 million …

Testing and treating mycobacterium tuberculosis infection

E Ortiz-Brizuela, D Menzies, MA Behr - Medical Clinics, 2022 - medical.theclinics.com
Globally, the incidence of tuberculosis (TB) is estimated at 9.9 million per year, of whom
nearly 1.5 million succumb to disease. 1 A subset of these individuals will never be detected …

Ending the tuberculosis syndemic: is COVID-19 the (in) convenient scapegoat for poor progress?

MX Rangaka, Y Hamada, I Abubakar - The Lancet Respiratory …, 2022 - thelancet.com
Comment 530 www. thelancet. com/respiratory Vol 10 June 2022 signifies that syndemic
approach. End TB outlines fundamentals required to modify determinants of ill health …

Re-evaluating progression and pathways following Mycobacteria tuberculosis infection within the spectrum of tuberculosis disease

KC Horton, AS Richards, JC Emery, H Esmail… - medRxiv, 2022 - medrxiv.org
Background Traditional understanding of the risk of progression from Mycobacterium
tuberculosis (Mtb) infection to tuberculosis (TB) disease overlooks nuance across a …

The crucial need for tuberculosis translational research in the time of COVID-19

FK Loh, PM Thong, CWM Ong - The Lancet Respiratory Medicine, 2022 - thelancet.com
The world is still grappling with the devastating effects of COVID-19 more than 2 years into
the pandemic. Countries with high COVID-19 vaccination rates are transitioning to the new …

[图书][B] Leveraging Metabolic Labeling Strategies to Study Mycobacterial Glycolipids

WR Sinclair - 2022 - search.proquest.com
Tuberculosis (TB) is a communicable disease spread through the air by the bacillus
Mycobacterium tuberculosis (Mtb). TB is a major global health burden and was the leading …